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Abstract
AIM: To investigate whether narrow band imaging 
(NBI) is a useful tool for the in vivo  detection of angio-
genesis in inflammatory bowel disease (IBD) patients. 
METHODS: Conventional and NBI colonoscopy was 
performed in 14 patients with colonic inflammation (8 
ulcerative colitis and 6 Crohn’s disease). Biopsy samples 
were taken and CD31 expression was assayed immuno-
histochemically; microvascular density was assessed by 
vessel count.
RESULTS: In areas that were endoscopically normal 
but positive on NBI, there was a significant (P  < 0.05) 
increase in angiogenesis (12 ± 1 vessels/field vs  18 ± 
2 vessels/field) compared with areas negative on NBI. 
In addition, in areas that were inflamed on white light 
endoscopy and positive on NBI, there was a significant (P 
< 0.01) increase in vessel density (24 ± 7 vessels/field) 
compared with NBI-negative areas. 
CONCLUSION: NBI may allow in vivo  imaging of in-
testinal angiogenesis in IBD patients.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Angiogenesis plays a crucial role in neoplastic and non-
neoplastic chronic inflammatory disorders[1-4], including 
the inflammatory bowel diseases (IBD), Crohn’s disease 
(CD) and ulcerative colitis (UC)[4,5]. Potent angiogenic 
activity has been demonstrated in histological specimens 
from the mucosa of  both UC and CD patients, as as-
sessed by CD31 staining[6]. Several reports have shown 
that blockade of  angiogenesis in preclinical models of  
IBD is a promising new therapeutic approach[7,8]. Narrow 
band imaging (NBI) is a new endoscopic technology that 
highlights mucosal surface structures and microcapillaries. 
Optical filters achieve sequential green and blue illumina-
tion, narrowing the bandwidth of  spectral transmittance, 
and thus obtaining tissue illumination at selected narrow 
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wavelength bands[9,10] to achieve the greatest contrast be-
tween vascular structures and the surrounding mucosa.
The diagnostic accuracy of  NBI in detecting colorec-
tal neoplasia in patients with or without concomitant UC 
is superior to conventional colonoscopy and equivalent 
to that of  chromoendoscopy[11,12]. A recent meta-analysis 
concluded that NBI is accurate, with high diagnostic pre-
cision for in vivo diagnosis of  neoplasia across a range of  
organs (colon, esophagus, duodenal ampulla and lung)[13].
Very recently, NBI has been proposed as a tool to as-
sess the grade of  inflammation in patients with inactive 
or mildly active UC[14]. In the preliminary study described 
herein, we investigated whether NBI colonoscopy could 
be a useful tool to detect in vivo angiogenesis in IBD pa-
tients with colonic inflammation.
MATERIALS AND METHODS
This was an open study involving patients with a diagno-
sis of  IBD referred to our Gastrointestinal Endoscopy 
Unit for follow-up colonoscopy. A total of  14 patients 
were included (8 UC and 6 colonic CD). The extent of  
the disease was determined by previous colonoscopy. 
At the time of  enrollment in the study, 3 (3/8) UC pa-
tients presented with inactive disease (Mayo score = 0) 
while 5 (5/8) had active disease (2 patients Mayo score 
= 1, 2 patients Mayo score = 2 and 1 patient Mayo score 
= 1); 3 (3/6) patients with CD presented with inactive 
disease and 3 (3/6) had active disease. For CD patients 
endoscopic activity was assessed by Crohn’s Disease 
Endoscopic Index of  Severity (CDEIS). After obtaining 
informed consent from all patients, white light colonos-
copy and NBI (Olympus Medical System, Tokyo, Japan) 
examinations were performed. 
For the white light colonoscopy, the vascular pattern 
was defined as normal if  it did not show any irregularities, 
or as distorted if  the pattern was tortuous. When the vas-
cular pattern intensity was visualized with NBI, we were 
able to distinguish 2 different mucosal patterns: a stronger 
(blacker) capillary vascular pattern (NBI+), and a milder 
or regular capillary vascular pattern (NBI-). For this rea-
son, in our study the vascular pattern could be classified 
into 4 categories: normal (with white light colonoscopy) 
and NBI-; distorted (with white light colonoscopy) and 
NBI-; normal (with white light colonoscopy) and NBI+; 
distorted (with white light colonoscopy) and NBI+.
For each patient, after determining the vascular pattern 
by NBI, biopsy specimens were obtained from 5 areas 
that were normal with conventional endoscopy and NBI-, 
5 areas that were normal with conventional endoscopy but 
NBI+, and 5 areas that were endoscopically inflamed and 
NBI+. CD31 staining was performed by immunohisto-
chemistry, and microvascular density was assessed by ves-
sel count in colonic biopsies. The pathologist was blinded 
to the subjects.
Statistical analysis
The parametric data are expressed as the mean ± SD 
and non parametric data as percent. Fischer’s exact prob-
ability test and the χ2 test were used to evaluate statistical 
differences. A P-value less than 0.05 was considered sta-
tistically significant.
RESULTS
For each of  the 14 patients enrolled in the study, the mu-
cosal vascular pattern was assessed by both conventional 
and NBI colonoscopy. 
Mucosal areas normal with white light colonoscopy and 
NBI-
In the uninflamed mucosa of  patients with IBD, classi-
fied as normal with white light colonoscopy and NBI-, 
the NBI pattern was similar to that in the mucosa from 
healthy control individuals. At the same time, the vascular-
ization pattern and the microvessel density, as revealed by 
CD31 staining, were similar in the specimens from the un-
inflamed, NBI- mucosa from patients with IBD and from 
healthy controls. No differences were found between UC 
and CD patients.
Comparison of NBI+ and NBI- areas that were normal 
with white light colonoscopy
Compared to areas that were endoscopically normal un-
der white light colonoscopy and NBI-, endoscopically 
normal but NBI+ areas displayed a significant (P < 0.05) 
increase in angiogenesis (12 ± 1 vessels/field vs 18 ± 
2 vessels/field) (Figure 1A and B). The importance of  our 
findings lies in the evidence that in patients with normal 
white light colonoscopy, areas positive on NBI showed an 
increased leukocyte infiltrate and a significantly increased 
microvessel density (P < 0.05) as assessed by histological 
analysis (Figure 1A-C). As revealed by staining for CD31, 
the mean microvessel diameter in IBD was 0.1 mm, a 
size histologically compatible with the diameter of  a dot 
observed on the NBI image. No differences were found 
between UC and CD patients (not shown).
Areas inflamed on white light colonoscopy and NBI+
Lastly, in areas from IBD patients that were inflamed un-
der white light endoscopy and were NBI+, a significant 
(P < 0.01) increase in vessel density (24 ± 7 vessels/field) 
was found compared with endoscopically normal, NBI- 
areas (Figure 2A and B), a finding compatible with a high 
degree of  microscopical inflammation and immune-driv-
en angiogenesis. No differences were found according to 
Mayo score in vessel density (not shown). No differences 
were found between UC and CD patients (not shown).
DISCUSSION
Angiogenesis is an integral component of  non-neoplas-
tic chronic inflammatory disorders, such as IBD[15,16]. 
Microscopic imaging is the approach that has thus far 
proven most valid for quantification of  vasculature in 
normal and pathological tissue[17-19]. NBI has been suc-
cessfully used to visualize angiogenesis and thereby to 
detect cancerous areas in the colon. Because of  the im-
proved mucosal contrast provided, NBI may improve 
the detection of  colon polyps compared with standard 
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white light colonoscopy. NBI has also been widely used 
to detect dysplasia in patients with long-standing UC, 
achieving good results in terms of  diagnostic accuracy 
and detection of  polyps, although if  did not show any 
statistically significant differences compared with stan-
dard white light colonoscopy[19,20]. 
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Figure 1  Colonic mucosa of healthy individuals and uninflamed but narrow-band imaging (NBI)+ regions from patients with inflammatory bowel disease 
(IBD), visualized using white light colonoscopy and NBI endoscopy. The microvasculature of histologically normal control and IBD uninflamed colonic mucosa 
was immunohistochemically stained for CD31 and von Willebrand/factor Ⅷ. There was increased vascularization in uninflamed IBD mucosa that presented an 
aberrant NBI+ pattern, in the NBI+ areas compared with controls. A: Healthy subjects. The vascular pattern was normal on both conventional colonoscopy and NBI, 
which was confirmed by immunohistochemical staining; B: Areas of the IBD mucosa that were not inflamed on conventional colonoscopy and showed an aberrant 
NBI+ pattern. Immunohistochemical staining confirmed an increased vascularization in these areas compared with NBI- areas; C: Computerized morphometric 
analysis of the microvasculature in control and IBD uninflamed mucosa that was NBI+. After immunohistochemical staining, sections were analyzed for the total 
number of vessels/field (microvascular density). aA statistically significant difference was found between sections from areas of uninflamed IBD colonic mucosa that 
were NBI+ and from controls.
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In a recently published study, NBI was proposed as a 
tool to assess the grade of  inflammation in patients with 
inactive or mildly active UC[12]. In our study, we found that 
NBI could also be used to visualize areas of  abnormal mi-
crovascular changes, not observed at white light colonos-
copy. A statistically significant correlation exists between 
NBI pattern positivity (both in inflamed and normal areas 
at conventional endoscopic examination) and microves-
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Figure 2  Inflamed colonic mucosa of IBD patients visualized using white light colonoscopy and NBI. The microvasculature of IBD inflamed colonic mucosa 
was immunohistochemically stained for CD31 and von Willebrand/factor Ⅷ. A: Areas of the IBD mucosa that were inflamed on white light colonoscopy showing an 
aberrant NBI+ pattern. There was increased vascularization in the inflamed IBD mucosa in areas where there was an aberrant NBI+ pattern, which was confirmed 
by immunohistochemical staining; B: Areas of the IBD mucosa that were not inflamed on conventional colonoscopy and showed an aberrant NBI+ pattern. 
Immunohistochemical staining confirmed an increased vascularization in these areas compared with NBI- areas; C: Computerized morphometric analysis of the 
microvasculature in the IBD inflamed mucosa. After immunohistochemical staining, sections were analyzed for the total number of vessels/field (microvascular 
density). aA statistically significant difference was found between sections from areas of inflamed IBD colonic mucosa that were NBI+ and areas of uninflamed IBD 
mucosa that were normal under white light colonoscopy but were NBI+ . 
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sel density, as confirmed by CD31 staining in histological 
specimens from the same areas. In patients who were nor-
mal under standard colonoscopy, there was increased leu-
kocyte infiltration and microvessel density in NBI+ areas, 
as assessed by histological analysis. 
Blockade of  angiogenesis could be beneficial in pa-
tients with chronic inflammation and some drugs that 
have demonstrated efficacy for the treatment of  IBD, 
such as tumor necrosis factor-α inhibitors, have potent 
antiangiogenic activity. Our preliminary findings suggest 
that NBI could be a novel tool for the in vivo assessment 
of  mucosal angiogenesis. However since our study is still 
a preliminary study because of  the limited number of  
patients, a larger study should be performed to define 
the exact role of  NBI in IBD patients, and the correla-
tion of  mucosal angiogenesis with endoscopic activity.
Endoscopic imaging and monitoring of  angiogenesis 
has the potential to be a valuable biomarker in monitor-
ing the grade of  intestinal inflammation in vivo, monitor-
ing response to and optimization of  available treatments, 
and finally in evaluating the response to new agents for 
the treatment of  IBD in randomized clinical trials. 
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